These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 8411646

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. [Recombinant human erythropoietin in anemia associated with pediatric cancer: study of the identification of predictors of response].
    León Molinari P, Jiménez Monteagudo M, Barona Zamora P, Riol Diego M, Castro Paz L, Sierrasesúmaga Ariznavarreta L.
    An Esp Pediatr; 1998 Jul; 49(1):17-22. PubMed ID: 9718761
    [Abstract] [Full Text] [Related]

  • 44. Response predicting factors to recombinant human erythropoietin in cancer patients undergoing platinum-based chemotherapy.
    González-Barón M, Ordóñez A, Franquesa R, Constenla M, Montalar J, Gili F, Camps C, Sancho JF, Pérez-Cachot P.
    Cancer; 2002 Dec 01; 95(11):2408-13. PubMed ID: 12436449
    [Abstract] [Full Text] [Related]

  • 45. A new induction schedule of epoetin alfa 40.000 IU in anemic patients with advanced lung cancer.
    Ariganello O, Mancuso A, Di Molfetta M, Diana F, Beccaglia P, Cortesi E, De Marinis F.
    Lung Cancer; 2004 Oct 01; 46(1):119-24. PubMed ID: 15364140
    [Abstract] [Full Text] [Related]

  • 46. Recombinant human erythropoietin in the treatment of multiple myeloma-associated anemia.
    Mittelman M, Zeidman A, Fradin Z, Magazanik A, Lewinski UH, Cohen A.
    Acta Haematol; 1997 Oct 01; 98(4):204-10. PubMed ID: 9401498
    [Abstract] [Full Text] [Related]

  • 47. Once-weekly epoetin beta (30,000 IU) in anemic patients with lung cancer receiving chemotherapy.
    Pirker R, Lehnert M, Minar W.
    Lung Cancer; 2007 Jan 01; 55(1):89-94. PubMed ID: 17084484
    [Abstract] [Full Text] [Related]

  • 48. Comparison of two epoetin brands in anemic hemodialysis patients: results of two efficacy trials and a single-dose pharmacokinetic study.
    Milutinović S, Plavljanić E, Trkulja V.
    Fundam Clin Pharmacol; 2006 Oct 01; 20(5):493-502. PubMed ID: 16968421
    [Abstract] [Full Text] [Related]

  • 49. Evaluation of the effectiveness of treatment with erythropoietin on anemia, cognitive functioning and functions studied by comprehensive geriatric assessment in elderly cancer patients with anemia related to cancer chemotherapy.
    Massa E, Madeddu C, Lusso MR, Gramignano G, Mantovani G.
    Crit Rev Oncol Hematol; 2006 Feb 01; 57(2):175-82. PubMed ID: 16213740
    [Abstract] [Full Text] [Related]

  • 50. Management of disease-related anemia in patients with multiple myeloma or chronic lymphocytic leukemia: epoetin treatment recommendations.
    Ludwig H, Rai K, Blade J, Dammacco F, Degos L, Itri L, Kyle R, Liso V, Littlewood TJ, Mandelli F, Meloni G, Molica S, Osterborg A, Pangalis GA, San Miguel J, Schmitt B, Voliotis D.
    Hematol J; 2002 Feb 01; 3(3):121-30. PubMed ID: 12111647
    [Abstract] [Full Text] [Related]

  • 51. Use of recombinant erythropoietin in the treatment of anaemia associated with multiple myeloma in a haemodialysis patient.
    Hussein MM, Mooij JM, Roujouleh H.
    Nephrol Dial Transplant; 1994 Feb 01; 9(7):876-7. PubMed ID: 7818713
    [No Abstract] [Full Text] [Related]

  • 52. Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: dose finding and identification of predictors of response.
    Cazzola M, Messinger D, Battistel V, Bron D, Cimino R, Enller-Ziegler L, Essers U, Greil R, Grossi A, Jäger G, LeMevel A, Najman A, Silingardi V, Spriano M, van Hoof A, Ehmer B.
    Blood; 1995 Dec 15; 86(12):4446-53. PubMed ID: 8541533
    [Abstract] [Full Text] [Related]

  • 53. Recombinant human erythropoietin corrects anemia of blood loss: a study in the dog.
    Koumegawa J, Kawahara J, Kubo K, Amano K, Wakimoto N, Takahashi K, Juji T, Takaku F.
    Int J Cell Cloning; 1990 Mar 15; 8(2):97-106. PubMed ID: 2313141
    [Abstract] [Full Text] [Related]

  • 54. Recombinant human erythropoietin is associated with increased overall survival in patients with multiple myeloma.
    Baz R, Walker E, Choueiri TK, Abou Jawde R, Brand C, McGowan B, Yiannaki E, Andresen S, Hussein MA.
    Acta Haematol; 2007 Mar 15; 117(3):162-7. PubMed ID: 17148935
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Anemia and infections in multiple myeloma: supportive therapy.
    Cáceres W, Santiago K, Paulo L, Román J.
    Bol Asoc Med P R; 2009 Mar 15; 101(2):50-2. PubMed ID: 19954102
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Beyond anaemia management: evolving role of erythropoietin therapy in neurological disorders, multiple myeloma and tumour hypoxia models.
    Boogaerts M, Mittelman M, Vaupel P.
    Oncology; 2005 Mar 15; 69 Suppl 2():22-30. PubMed ID: 16244507
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.